IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,533,824 | +11.5% | 2,490,600 | -3.2% | 0.01% | +16.7% |
| Q1 2023 | $15,721,586 | -4.9% | 2,573,091 | -0.6% | 0.01% | -7.7% |
| Q4 2022 | $16,534,879 | -36.1% | 2,587,618 | -4.1% | 0.01% | -38.1% |
| Q3 2022 | $25,860,000 | -16.3% | 2,699,413 | -3.6% | 0.02% | -12.5% |
| Q2 2022 | $30,908,000 | -21.9% | 2,799,642 | +17.7% | 0.02% | -7.7% |
| Q1 2022 | $39,599,000 | -58.2% | 2,378,336 | -52.1% | 0.03% | -55.2% |
| Q4 2021 | $94,784,000 | -39.8% | 4,965,096 | -22.2% | 0.06% | -40.8% |
| Q3 2021 | $157,351,000 | -21.8% | 6,380,803 | -17.5% | 0.10% | -17.6% |
| Q2 2021 | $201,333,000 | +19.9% | 7,737,618 | +45.9% | 0.12% | +13.3% |
| Q1 2021 | $167,885,000 | -18.2% | 5,302,733 | +19.9% | 0.10% | -21.1% |
| Q4 2020 | $205,269,000 | +77.2% | 4,423,910 | +25.7% | 0.13% | +70.5% |
| Q3 2020 | $115,870,000 | +52.9% | 3,519,745 | +27.5% | 0.08% | +44.4% |
| Q2 2020 | $75,777,000 | +125.9% | 2,760,546 | +146.4% | 0.05% | +86.2% |
| Q1 2020 | $33,543,000 | -8.6% | 1,120,522 | -15.5% | 0.03% | 0.0% |
| Q4 2019 | $36,718,000 | +48.7% | 1,326,509 | -2.2% | 0.03% | +38.1% |
| Q3 2019 | $24,685,000 | -20.4% | 1,356,302 | +7.3% | 0.02% | -25.0% |
| Q2 2019 | $30,996,000 | +616.8% | 1,264,096 | +178.0% | 0.03% | +600.0% |
| Q1 2019 | $4,324,000 | – | 454,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |